Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Foghorn Therapeutics Inc. Common Stock (FHTX)

Pharmaceutical Preparations

https://www.foghorntx.com

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

500 TECHNOLOGY SQUARE, SUITE 700
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/23/2020

Market Cap

349,124,097

Shares Outstanding

42,220,000

Weighted SO

42,217,126

Total Employees

N/A

Upcoming Earnings

08/02/2024

Similar Tickers

CCCC --.--%

CYT --.--%

PRLD --.--%

RZLT --.--%

STTK --.--%

GLUE --.--%

KYMR --.--%

NRIX --.--%

MOLN --.--%

Beta

3.1020

Last Div

0.0000

Range

2.7-8.62

Chg

0.1100

Avg Vol

108151

Mkt Cap

349124097

Exch

NASDAQ

Country

US

Phone

617 586 3100

DCF Diff

6.5649

DCF

-0.0249

Div Yield

0.0000

P/S

9.9225

EV Multiple

-2.7407

P/FV

-22.7253

Div Yield %

0.0000

P/E

-3.7650

PEG

-0.3523

Payout

0.0000

Current Ratio

5.6932

Quick Ratio

5.6932

Cash Ratio

2.7314

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

524.2450

CCC

-524.2450

Gross Margin

0.9048

Op Margin

-2.6991

Pretax Margin

-2.3795

Net Margin

-2.4569

Eff Tax Rate

-0.0420

ROA

-0.2631

ROE

1.4034

ROCE

-0.3420

NI/EBT

1.0325

EBT/EBIT

0.8816

EBIT/Rev

-2.6991

Debt Ratio

0.1245

D/E

-2.8569

LT Debt/Cap

1.7861

Total Debt/Cap

1.5385

Int Coverage

-41.8541

CF/Debt

-2.6795

Equity Multi

-22.9427

Rec Turnover

0.0000

Pay Turnover

0.6962

Inv Turnover

0.0000

FA Turnover

0.9705

Asset Turnover

0.1071

OCF/Share

-2.1255

FCF/Share

-2.1301

Cash/Share

5.5288

OCF/Sales

-3.1159

FCF/OCF

1.0022

CF Coverage

-2.6795

ST Coverage

-13.0905

CapEx Coverage

-462.5865

Div&CapEx Cov

-462.5865

P/BV

-22.7253

P/B

-22.7253

P/S

9.9225

P/E

-3.7650

P/FCF

-3.1776

P/OCF

-2.9687

P/CF

-2.9687

PEG

-0.3523

P/S

9.9225

EV Multiple

-2.7407

P/FV

-22.7253

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation